The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression

Neuron. 2006 Feb 2;49(3):341-8. doi: 10.1016/j.neuron.2005.12.027.

Abstract

Mutations in the MECP2 gene cause Rett syndrome (RTT). Bdnf is a MeCP2 target gene; however, its role in RTT pathogenesis is unknown. We examined Bdnf conditional mutant mice for RTT-relevant pathologies and observed that loss of BDNF caused smaller brain size, smaller CA2 neurons, smaller glomerulus size, and a characteristic hindlimb-clasping phenotype. BDNF protein level was reduced in Mecp2 mutant mice, and deletion of Bdnf in Mecp2 mutants caused an earlier onset of RTT-like symptoms. To assess whether this interaction was functional and potentially therapeutically relevant, we increased BDNF expression in the Mecp2 mutant brain with a conditional Bdnf transgene. BDNF overexpression extended the lifespan, rescued a locomotor defect, and reversed an electrophysiological deficit observed in Mecp2 mutants. Our results provide in vivo evidence for a functional interaction between Mecp2 and Bdnf and demonstrate the physiological significance of altered BDNF expression/signaling in RTT disease progression.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Action Potentials / genetics
  • Action Potentials / radiation effects
  • Animals
  • Animals, Newborn
  • Behavior, Animal
  • Brain / metabolism
  • Brain / pathology
  • Brain-Derived Neurotrophic Factor / deficiency
  • Brain-Derived Neurotrophic Factor / genetics
  • Brain-Derived Neurotrophic Factor / metabolism*
  • Disease Models, Animal
  • Disease Progression
  • Electric Stimulation / methods
  • Enzyme-Linked Immunosorbent Assay / methods
  • Female
  • Gene Expression Regulation / genetics
  • Humans
  • Immunohistochemistry / methods
  • In Vitro Techniques
  • Male
  • Methyl-CpG-Binding Protein 2 / deficiency
  • Methyl-CpG-Binding Protein 2 / genetics*
  • Mice
  • Mice, Knockout
  • Motor Activity / genetics
  • Mutation / physiology*
  • Neurons / physiology
  • Organ Size / genetics
  • Patch-Clamp Techniques / methods
  • RNA, Messenger / metabolism
  • Rett Syndrome / genetics*
  • Rett Syndrome / metabolism
  • Rett Syndrome / physiopathology
  • Reverse Transcriptase Polymerase Chain Reaction / methods

Substances

  • Brain-Derived Neurotrophic Factor
  • Mecp2 protein, mouse
  • Methyl-CpG-Binding Protein 2
  • RNA, Messenger